News

Eltek Welcomes Tomer Segev as New Marketing and Sales VP

Eltek Welcomes Tomer Segev as New Marketing and Sales VP

Introducing Tomer Segev: Eltek's New Vice President

Eltek Ltd. (NASDAQ: ELTK), a prominent player in the printed circuit board sector, has made a noteworthy addition to its leadership team. Tomer Segev has been appointed as the new Vice President of Marketing and Sales, effective immediately. This move underscores Eltek's dedication to boosting sales growth and enhancing its market strategy.

Tomer Segev's Experience and Expertise

With over 20 years of experience in the technology and electronics industries, Tomer Segev brings a wealth of knowledge to Eltek. His impressive background includes leading global sales initiatives and executing strategic marketing campaigns that have successfully broadened market reach. In his new role, he will manage all global sales operations and support the marketing team as they strive to expand Eltek's presence in key markets.

Insights from the CEO

CEO Eli Yaffe shared his enthusiasm for Tomer's appointment, stating, "We are thrilled to welcome Tomer to the Eltek leadership team. His remarkable history of building high-performance teams and driving substantial revenue growth will be vital as we continue our journey of innovation in delivering top-quality PCBs to our clients worldwide. Tomer's leadership will be crucial in strengthening our position in the industry and accelerating our growth strategy."

Tomer Segev's Previous Roles and Educational Background

Prior to joining Eltek, Tomer Segev held senior leadership roles at several prestigious global technology companies, including PCB Technologies, Camtek, Orbotech, and KLA. In these positions, he excelled in sales and marketing, effectively addressing challenges in business management and development. Tomer earned a Bachelor of Science degree in Physics and Materials Engineering from the Technion, along with an MBA from the Kellogg-Recanati Executive MBA program at Northwestern University and Tel Aviv University.

Segev's Vision for Eltek

Expressing his excitement about joining Eltek, Tomer Segev remarked, "I am excited to be part of Eltek and to play a role in the company’s growth and success in this fast-paced market. I look forward to working with the talented team at Eltek to continue providing cutting-edge solutions and exceptional service to our customers." His vision is centered on enhancing Eltek's capabilities within the competitive landscape of the PCB industry.

About Eltek Ltd.

Eltek, recognized for its slogan "Innovation Across the Board," is a leading manufacturer of advanced printed circuit board solutions. By consistently pursuing excellence, Eltek has established itself as a key player in the industry, particularly in the realm of complex and high-quality PCBs. These products are vital components in most electronic devices and are designed to meet the stringent demands of sectors such as defense, aerospace, and medical.

Global Presence and Compliance

Founded in 1970, Eltek operates from its headquarters, which houses R&D, production, and marketing teams. The company also has a subsidiary in North America and works with agents and distributors across Europe, India, South Africa, and South America. Eltek adheres to ITAR regulations and holds prestigious certifications, including AS-9100 and NADCAP in electronics.

Frequently Asked Questions

Who is Tomer Segev?

Tomer Segev is the newly appointed Vice President of Marketing and Sales at Eltek Ltd., bringing over 20 years of industry experience.

What is Eltek's main industry focus?

Eltek specializes in manufacturing printed circuit boards and innovative solutions for various electronic applications.

What is Eltek's motto?

Eltek's motto is "Innovation Across the Board," highlighting their commitment to technological advancement.

Where is Eltek headquartered?

The company's headquarters, along with its R&D and production facilities, are located in Israel.

What industries does Eltek serve?

Eltek primarily serves the defense, aerospace, and medical industries with its advanced PCB solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bladex Declares Quarterly Dividend for Q3 2026

Updated Category News Views 85

Bladex's Steady Dividend: What's Under the Hood? Well, well, it looks like Bladex is doing the old dividend dance again. They've just announced a quarterly cash dividend of $0.6875 per share for the third quarter of 2026. It's scheduled for payout on November 24 to those who have their noses in the ledger come November 6—that's your record date, folks. Now, dividends...

Continue Reading
Bybit’s Gold Yield Offer: 2.83% APR on XAUT

Updated Category News Views 41

Gold Savings with a Tokenized Twist Taking a wild swing at pairing gold and crypto in a digestible package, Bybit and the XAUE Protocol have teamed up to offer a 2.83% fixed APR on XAUT Savings. If you're itching for something that doesn’t make your stomach churn like some of the wild crypto rides, this just might soothe those nerves. Or maybe it’s just a slick way to...

Continue Reading
Essential Oils Market Booms; Hits $29.52Bn by 2031

Updated Category News Views 90

Essential Oils: Aromatherapy's New Frontier and Pharma Ally What’s the deal with essential oils? Well, it seems they’re not just for your neighbor’s pricey diffuser anymore. According to some fresh numbers, we're staring down a market worth nearly $30 billion by 2031. And it ain't all incense and hippie stores fueling this beast — we're talking a serious expansion...

Continue Reading
Anti-Corruption Titans Gather for Key 20-Year IAACA Event

Updated Category News Views 35

Strength in Unity: A Global Anti-Corruption Gathering Here's a scene you don't stumble upon every day: corruption busters from all corners of the globe converging on Marrakech. The International Association of Anti-Corruption Authorities (IAACA) is rolling out the red carpet for its 20th-anniversary conference, a get-together poised to serve up not just pastries and...

Continue Reading
Coulomb Solutions Powers Ahead with ReadyGrid Launch

Updated Category News Views 25

Breaking New Ground with ReadyGrid If you've been keeping an eye on the energy storage landscape, today's a big day. Coulomb Solutions, Inc. (CSI) is shaking things up by spinning off ReadyGrid, its own dedicated mobile energy storage powerhouse. The move is designed to tackle the pressing power challenges that have been nagging industries across the board, from...

Continue Reading
Big Tree Cloud Files Annual Report, Eyes AI Expansion

Updated Category News Views 82

Annual Reports and Long-Term Vision God, does the stock market love itself some annual filings. Anyway, Big Tree Cloud Holdings Limited (NASDAQ: DSY) just went and did their annual rigmarole with the 20-F form for the fiscal year ending June 2026. Filed with the SEC, they're letting shareholders and the interested masses know—plainly, and probably...

Continue Reading
Workers at CertainTeed Plant Unionize with Teamsters

Updated Category News Views 218

Unity at CertainTeed Sends Ripples through Industry Here's something that'll stir your coffee: 170 workers at CertainTeed's fiberglass facility in Chowchilla, California, just decided they won't take management's antics lying down. These folks voted to join Teamsters Local 431, aiming for some long-overdue respect and a contract that'll guarantee better wages and...

Continue Reading
Sands China's Latest Move: A Bond Offering Twist

Updated Category News Views 74

Breaking Down Sands China's Bond Maneuver Today, we found out that Sands China is teeing up a fresh round of senior unsecured notes. Now, if that doesn't get your ticker flickin', maybe you're too used to market snoozefests. The folks at the helm of Sands China, a subsidiary under the mighty Las Vegas Sands Corp. (NYSE: LVS), are rolling out these USD-denominated notes...

Continue Reading
Tempo's Protein Max Meals: A High-Protein Revolution

Updated Category News Views 8

Packed Protein, Zero Hassle Every once in a while, something comes along in the food sector that changes the game. Tempo's Protein Max meals might just be it. Launching with a hefty 40 grams of protein in every serving, these meals promise a powerful punch for anyone who's serious about meeting their protein counts without spending hours in the kitchen. Two minutes flat...

Continue Reading
Steel Vet Shift: John Pritchett Takes Helm at Trojan

Updated Category News Views 6

Trojan Steel's Bold Move with John Pritchett at the Helm Trojan Steel is changing the game by appointing John C. Pritchett as its new President. This isn't just another shuffle of suits in the boardroom—it's a statement. Pritchett isn't some steel industry old-timer; instead, he's a business leader with a knack for scaling operations. With a resume that includes...

Continue Reading

Top 5 Most Recently Viewed Articles

Festi hf. Issues New Six-Month Bill with Attractive Rates

Updated Category News Views 185

Festi hf. Issues New Six-Month Bill Festi hf. has reached a significant milestone by completing the issuance of a new six-month bill, designated as FESTI260616, amounting to ISK 1,300 million. This issuance comes with a competitive flat interest rate of 7.94%, making it an appealing option for investors. Details of the Bill Issuance Contrary to traditional public...

Continue Reading
Senior Helpers East San Diego Secures CHAP Care Certification

Updated Category News Views 133

Senior Helpers East San Diego Achieves Age-Friendly Care Certification Senior Helpers, a leading provider of in-home senior care services, has made history by becoming the first private duty in-home care organization in the United States to earn the Age-Friendly Care at Home certification from Community Health Accreditation Partners (CHAP). On a recent date in March 2025,...

Continue Reading
Cesar Millan Launches Innovative Supplements for Dogs

Updated Category News Views 280

A New Beginning for Canine Wellness Cesar Millan, the beloved original host of The Dog Whisperer TV series, continues to shine in the global spotlight. His latest venture, Better Dog Supplements™, is a NASC-certified line of products, aiming to revolutionize canine health. With an impressive social media presence generating over 100 million views monthly across...

Continue Reading
Recent Share Transactions by Danske Bank Management Teams

Updated Category News Views 55

Significant Transactions by Danske Bank A/S Management Danske Bank A/S has recently made notable transactions involving its managerial personnel as part of the share buy-back program. This initiative aims to enhance shareholder value while maintaining a robust operational framework. The transactions made by individuals who have managerial responsibilities are crucial, as...

Continue Reading
Latest Updates on Xilio Therapeutics: Pipeline and Financials

Updated Category News Views 149

Xilio Therapeutics Updates Its Pipeline and Financial Performance Late-breaking Phase 2 results revealed a 40% objective response in heavily pretreated MSS mCRC patients without liver metastases, showcasing significant therapeutic potential. Phase 1 data for efarindodekin alfa displayed promising anti-tumor effects along with a well-tolerated safety profile in patients...

Continue Reading